Table 2.
Label | Training (N = 132) | Validation (N = 19) | Testing (N = 219) |
---|---|---|---|
No. of ROIs | No. of ROIs | No. of ROIs | |
Non-ODG glioma | 17,580 (N = 113) | 1954 (N = 16) | 4884 (N = 203) |
ODG | 9461 (N = 19) | 1052 (N = 3) | 2617 (N = 16) |
ODG, oligodendroglioma; ROI, region of interest.